EUVIMEDEUVIMED entdecken
Open Access

Glial-to-mesenchymal transition of tumor Schwann cells drives the genetic burden in MPNSTs from neurofibromatosis type 1 mouse model

Katarzyna J Radomska iD, Audrey Onfroy iD, Laure Lecerf iD, Bastien Job iD, Aurélien Beaude iD, Laura Sesma Sanz iD, Tatiana El Jalkh iD, Denis Thieffry iD, Patrick Charnay iD, Pierre Wolkenstein, Nicolas Ortonne iD, Fanny Coulpier iD und 1 weitere

Science Advances · 14.11.2025 · 11 (46)

DOI: 10.1126/sciadv.adt9210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 14.11.2025. Verfasst von Katarzyna J Radomska und 12 weiteren Autor:innen. Beteiligte Einrichtung: Mondor Institute for Biomedical Research (IMRB), INSERM, Créteil, France. Hauptthemen laut MEDLINE: Schwann Cells, Neurofibromatosis 1, Nerve Sheath Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is currently no effective treatment for malignant peripheral nerve sheath tumors (MPNSTs), half of which result from malignant progression of neurofibromas (NFs) in patients with neurofibromatosis type 1 (NF1). NFs are due to biallelic loss-of-function of NF1, which negatively regulates the RAS pathway, in the Schwann cell lineage. We generated a conditional Nf1-mutant mouse model where NFs spontaneously transform into MPNSTs, faithfully recapitulating the human situation. Single-cell transcriptomic profiling demonstrated progression of NFs into MPNSTs, with a glial-to-mesenchymal transition. Sox9 was identified as a marker of this transition and key player in tumor growth. The transition is followed by a loss of the tumor suppressor gene (TSG) Cdkn2a and acquisition of pathogenic variants of other TSGs. Finally, a proof-of-concept drug screen aimed at reducing Sox9 expression in tumor cells identified 12 FDA-approved drugs. Notably, several of these agents target the RAS signaling cascade, suggesting that multi-targeted inhibition of this pathway may represent a promising therapeutic strategy against MPNSTs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Schwann CellsNeurofibromatosis 1Nerve Sheath NeoplasmsAnimalsMiceDisease Models, AnimalSOX9 Transcription FactorNeurofibromin 1HumansGene Expression Regulation, NeoplasticSignal TransductionGene Expression Profiling

Substanzen

SOX9 Transcription FactorNeurofibromin 1Sox9 protein, mouse

Autor:innen und Institutionen

  • Mondor Institute for Biomedical Research (IMRB), INSERM, Créteil, France.
  • Ecole Normale Supérieure, PSL Research University, CNRS, INSERM, Institut de Biologie de l'Ecole Normale Supérieure (IBENS), Paris, France.
  • Gustave Roussy Institute of Oncology, Villejuif, France.
  • National Phenotypic Screening Centre, School of Life Sciences, University of Dundee, Dundee, UK.
  • Department of Dermatology, Reference Center for Neurofibromatosis, Henri-Mondor Hospital, AP-HP, Créteil, France.
  • Department of Pathology, Henri-Mondor Hospital, AP-HP, Créteil, France.

ORCID-Profile: Katarzyna J Radomska, Audrey Onfroy, Laure Lecerf, Bastien Job, Aurélien Beaude, Laura Sesma Sanz, Tatiana El Jalkh, Denis Thieffry, Patrick Charnay, Nicolas Ortonne, Fanny Coulpier, Piotr Topilko

Zitieren

APA

Radomska, K. J., Onfroy, A., Lecerf, L., Job, B., Beaude, A., Sanz, L. S., El Jalkh, T., Thieffry, D., Charnay, P., Wolkenstein, P., Ortonne, N., Coulpier, F., & Topilko, P. (2025). Glial-to-mesenchymal transition of tumor Schwann cells drives the genetic burden in MPNSTs from neurofibromatosis type 1 mouse model. Science Advances, 11(46). https://doi.org/10.1126/sciadv.adt9210

Vancouver

Radomska KJ, Onfroy A, Lecerf L, Job B, Beaude A, Sanz LS, et al. Glial-to-mesenchymal transition of tumor Schwann cells drives the genetic burden in MPNSTs from neurofibromatosis type 1 mouse model. Science Advances. 2025;11(46). doi:10.1126/sciadv.adt9210

BibTeX
@article{Radomska2025,
  author = {Radomska, Katarzyna J and Onfroy, Audrey and Lecerf, Laure and Job, Bastien and Beaude, Aurélien and Sanz, Laura Sesma and El Jalkh, Tatiana and Thieffry, Denis and Charnay, Patrick and Wolkenstein, Pierre and Ortonne, Nicolas and Coulpier, Fanny and Topilko, Piotr},
  title = {Glial-to-mesenchymal transition of tumor Schwann cells drives the genetic burden in MPNSTs from neurofibromatosis type 1 mouse model},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {46},
  doi = {10.1126/sciadv.adt9210}
}
Kostenlos starten →